Sexually transmitted infections (STIs) pose serious and continuing risks to the health and well-being of hundreds of millions of women and men. FHI 360’s global research and programmatic efforts span three decades in this critical area of disease prevention and health promotion.
FHI 360 leads the operations center of the STI Clinical Trials Group, funded by the U.S. National Institutes of Health, and provides data management to support the center’s research on the diagnosis, treatment and prevention of sexually transmitted infections.
Prevention and treatment of STIs requires an integrated mindset that goes beyond the basic sciences. At FHI 360, we know that the psychological, social, cultural and spiritual dimensions of human behavior are equally as important. FHI 360’s STI programs include:
- Testing STI interventions in a variety of populations
- Strengthening the public health response to STIs
- Improving the quality of STI preventive and curative services
- Developing and implementing interventions, including faith-based initiatives, for groups with the highest rates of STI exposure
- Improving the reliability of surveillance and evaluation data to guide efforts and measure progress
- Supporting the use of more focused disease-control measures to reduce the prevalence of specific STIs
- Generating and disseminating evidence-based information to guide global STI prevention efforts
